dr. scagliotti on egfr targeted therapy survival benefits
Published 12 years ago • 220 plays • Length 0:54Download video MP4
Download video MP3
Similar videos
-
1:37
dr. scagliotti discusses egfr mutations in nsclc
-
0:55
dr. giorgio scagliotti on combining targeted therapies with chemotherapy
-
1:47
dr. scagliotti on mechanisms of resistance to egfr tkis
-
1:16
dr. scagliotti on treating egfr-mutated tumors with afatinib
-
4:41
upfront egfr-targeted therapy for nsclc
-
1:32
dr. scagliotti discusses elderly lung cancer therapy
-
1:25
dr. giorgio scagliotti discusses afatinib in patients with egfr mutation
-
8:27
egfr-targeted therapy for squamous ncslc
-
5:10
sequencing egfr-targeted therapies in nsclc
-
1:59
dr. scagliotti on lung cancer treatment-related toxicities
-
1:49
dr. scagliotti on toxicities related to surgery and chemotherapy in patients with lung cancer
-
1:00
dr. villaruz on egfr-targeted therapies in nsclc
-
1:22:21
egfr breakout video targeted therapies 2017
-
4:09
frontline afatinib in egfr-mutant nsclc
-
0:50
treating patients with egfr-mutant lung cancer with targeted therapies
-
4:04
treating with osimertinib in egfr-mutated nsclc
-
57:37
emerging role of egfr-targeted therapy in resectable lung cancer
-
3:28
treating beyond progression in egfr-mutant lung cancer
-
4:07
chemotherapy with i-o therapy in egfr- or alk-mutated nsclc